Product
CANAKINUMAB ( INYECTABLE)
Code 101741 · Official unit: AMPOLLA
$ 76.962.727
Reported spend
53Contracts
1Buying agencies
2Suppliers
53Items bought2023–2025
The Uruguayan state bought CANAKINUMAB ( INYECTABLE) across 53 awards between 2023 and 2025. 1 agencies took part. The agency that bought most is Dirección General de la Salud. The supplier that sold most is MURRY S A.
Purchases by year
Who sells it
Suppliers that sold this product to the state most often.
Supplier concentration
How few suppliers account for this product's purchases: few suppliers signals a captive market.
Price dispersion
Unit-price range per currency and unit (p25 – p50 – p95). The wider the bar, the more what's paid varies.
Price reference
Price distribution per unit and currency over the last 36 months — the same baseline the price flags use.
| Unit | Typical (median) | Usual range | Comparables |
|---|---|---|---|
| USD · ampolla | US$ 31.500 USD | US$ 31.500 – 31.500 | 47 |